Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-(diphenylmethyl)-4-(3-(2-phenyl-1,3-dioxalen-2-yl)propyl)piperazine
1. 84625-59-2
2. Dotarizine [inn]
3. Dotarizinum
4. Dotarizina
5. 1-benzhydryl-4-[3-(2-phenyl-1,3-dioxolan-2-yl)propyl]piperazine
6. Io7663s6d3
7. 1-(diphenylmethyl)-4-(3-(2-phenyl-1,3-dioxolan-2-yl)propyl)piperazine
8. Dotarizinum [latin]
9. Dotarizina [spanish]
10. 1-benzhydryl-4-(3-(2-phenyl-1,3-dioxolan-2-yl)propyl)piperazine
11. 1-(diphenylmethyl)-4-[3-(2-phenyl-1,3-dioxolan-2-yl)propyl]piperazine
12. Unii-io7663s6d3
13. Fi-6026
14. Dotarizine [mi]
15. Irganox259
16. Mls006010920
17. Schembl333044
18. Chembl2106316
19. Dtxsid60233630
20. Chebi:138033
21. Zinc22058279
22. Piperazine, 1-(diphenylmethyl)-4-(3-(2-phenyl-1,3-dioxolan-2-yl)propyl)-
23. Db06446
24. Smr002530536
25. Db-056814
26. Ft-0630930
27. Q5299417
28. 1-(diphenylmethyl)-4-[3-(2-phenyl-1,3-dioxolan-2-yl)]piperazine
29. 1-(diphenylmethyl)-4-[3-(2-phenyl-1,3-dioxolan-2-yl)propyl]-piperazine
30. 1-(diphenylmethyl)-4-[3-(2-phenyl-1,3-dioxolan-2-yl)propyl]piperazin
Molecular Weight | 442.6 g/mol |
---|---|
Molecular Formula | C29H34N2O2 |
XLogP3 | 4.9 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 8 |
Exact Mass | 442.262028332 g/mol |
Monoisotopic Mass | 442.262028332 g/mol |
Topological Polar Surface Area | 24.9 Ų |
Heavy Atom Count | 33 |
Formal Charge | 0 |
Complexity | 534 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in migraine and cluster headaches.
Serotonin Antagonists
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)
Calcium Channel Blockers
A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?